Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › dalfampridine

dalfampridine

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of dalfampridine

6 trials tracked of dalfampridine: 1 in phase 3 or 4 and 1 with published results. The most-cited published study has 22 citations.

6Trials tracked
1Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 3 1 Phase 2 4 Other / NA 1
  1. Phase 3 Effects of Dalfampridine on Cognition in Multiple Sclerosis Completed · 22 cited
  2. Phase 2 Safety and Efficacy of Sustained Release Dalfampridine in Transverse Myelitis (Re-Launch) Completed
  3. Phase 2 Dalfampridine for Imbalance in Multiple Sclerosis Completed
  4. Phase 2 Study and Treatment of Visual Dysfunction and Motor Fatigue in Multiple Sclerosis Completed
  5. Phase 2 Effect of Dalfampridine (4-AP) on Genioglossus Muscle Activity in Healthy Adults Completed
  6. N/A Dalfampridine and Gait in Spinocerebellar Ataxias Completed

Showing the 6 most-cited and recently-updated of 6 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.